Ledger.Open graph →
SEC Form D · filed June 15, 2021

Orion Biotechnology Canada Ltd

Offering
$15.0M
Sold
$5.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
OTTAWA, Ontario, Canada
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

John S. Jussup · Ottawa, Ontario, CanadaExecAnatole S. Klepatsky · Ottawa, Ontario, CanadaExec · DirectorJason S. Burke · Ottawa, Ontario, CanadaExecDmytro S. Martynenko · Ottawa, Ontario, CanadaDirectorTheresa S. Firestone · Ottawa, Ontario, CanadaDirectorMark Groper · Ottawa, Ontario, CanadaExec · DirectorThomas S. Hecht · Ottawa, Ontario, CanadaDirectorRudolf Bom · Ottawa, Ontario, CanadaDirectorECP Investment Advisors LLC · Dallas, TXExec · DirectorJeffrey K. Quake · Stamford, CTDirectorJohn A. Hill · Stamford, CTDirectorMichael Lavalle · Santa Monica, CADirectorGary D. Reaves Ii · Houston, TXExec · DirectorAlex T. Krueger · Stamford, CTExecJohn W. Honeybourne · Houston, TXExecEmily Harburg · Chicago, ILDirectorRichard Kane · Boston, MADirectorDonald W. Wilson · Memphis, TNExec · DirectorKem W. Wilson Ill · Memphis, TNDirectorMclean W. Wilson · Memphis, TNExec · DirectorNicholas Campesi · Baton Rouge, LADirectorAngel Onuoha-Onyekuru · Conroe, TXExecGPE X GP Limited Partnership · Boston, MADirectorTomasso Montagni · New York, NYExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗